Re: Does PC-SPES interact with warfarin?
Duncan, Graeme G.
; 169(1): 294-5, 2003 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-12478174
A randomized, double-blind, placebo-controlled trial to evaluate the role of curcumin in prostate cancer patients with intermittent androgen deprivation.
Conséquences indirectes du dosage du PSA dans le dépistage du cancer de la prostate.
Laparoscopic and robotic-assisted versus open radical prostatectomy for the treatment of localised prostate cancer.
Disseminated intravascular coagulation and PC-SPES: a case report and literature review.
Effect of phosphodiesterase type 5 inhibitors on prostate cancer risk and biochemical recurrence after prostate cancer treatment: A systematic review and meta-analysis.
Early versus deferred standard androgen suppression therapy for advanced hormone-sensitive prostate cancer.
Outcomes of treatment in men with prostate cancer at the cancer centre Bahamas.
Taxane-based chemohormonal therapy for metastatic hormone-sensitive prostate cancer.
A Placebo-Controlled Double-Blinded Randomized Pilot Study of Combination Phytotherapy in Biochemically Recurrent Prostate Cancer.
Prostate cancer in renal transplant recipients.